Switch to:
More From Other Websites
As Cost Panel Gets Delayed, Buy These 3 Biotech ETFs Jun 23 2016
Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead May 17 2016
What Lies Ahead for Biotech ETFs? May 13 2016
Will the Current Pipeline Help Medivation Go beyond Xtandi? May 12 2016
The Story behind Medivation’s Rising Collaboration Revenue May 11 2016
A Promising Uptake for Vertex’s Orkambi May 04 2016
Biotech ETFs Sink on Mixed Q1 Results May 02 2016
2 Dirt-Cheap Big Pharma Stocks Poised to Beat Biotech's Bad Rap May 02 2016
Why Is Medivation at a Premium on an EV-to-EBITDA Basis? Apr 14 2016
A Rare Opportunity With A Biotechnology ETF Mar 17 2016
Is The Biotech Bear Market Over? Feb 29 2016
6 Top-Ranked ETFs to Rebound on Bargain Hunt Feb 25 2016
Some Traders Aren't Shy About Betting On A Biotech Rebound Feb 19 2016
Biotech ETFs Slide as Stocks Report Mixed Q4 Results Feb 09 2016
Tracking The Biotech Bubble's Bust Jan 31 2016
Celgene’s Valuation Is Higher Than Its Peers Jan 25 2016
What Are Analysts’ Expectations for BioMarin? Jan 19 2016
New ETF Is A Refined Pharmaceuticals Play Jan 14 2016
Van Eck Launches Market Vectors® Generic Drugs ETF (GNRX) Jan 13 2016
Bristol-Myers CEO: Looking forward to 2016 Jan 12 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK